Significant increases in Fuc levels and glycan branching in Hpt have been found to be associated with ovarian cancer [21], [30], lung cancer [31], pancreatic cancer [23], colon cancer [32] and hepatocellular carcinoma [33]. This evidence concerns the gene MRS2 and lung carcinoma.